Factors associated with mortality in patients with autoimmune diseases admitted to the Intensive Care Unit in Bogota, Colombia.

dc.contributor.authorCarrizosa, Jorge Armando
dc.contributor.authorAponte Monsalve, Jorge
dc.contributor.authorCartagena Agudelo, Diego Alejandro
dc.contributor.authorCervera i Segura, Ricard, 1960-
dc.contributor.authorOspina, Maria Teresa
dc.contributor.authorSánchez, Alexander
dc.date.accessioned2019-09-09T14:31:55Z
dc.date.available2019-09-09T14:31:55Z
dc.date.issued2017-03-23
dc.date.updated2019-09-09T14:31:55Z
dc.description.abstractPatients with autoimmune diseases (ADs) are a challenge for the intensivist; it is hard to differentiate among infection, disease activity, and combinations of both, leading to high mortality. This study is a retrospective analysis of 124 critically ill patients admitted to the intensive care unit (ICU) in a university hospital between 2008 and 2016. Bivariate case-control analysis was performed, using patients who died as cases; later, analysis using a logistic regression model with variables that were associated with mortality was conducted. Four variables were consistently associated with mortality in the logistic regression model and had adequate prediction value (Hosmer and Lemeshow statistic = 0.760; Nagelkerke R-squared = 0.494). The risk of death was found to be statistically associated with the following: shock at admission to ICU [odds ratio (OR): 7.56; 95% confidence interval (CI): 1.78-31.97, p = 0.006], hemoglobin level <8 g/dL (OR: 16.12; 95% CI: 3.35-77.52, p = 0.001), use of cytostatic agents prior to admission to the ICU (OR: 8.71; 95% CI: 1.23-61.5, p = 0.03), and low levels ofcomplement C3 (OR: 5.23; 95% CI: 1.28-21.35, p = 0.02). These variables can guide clinicians in the early identification of patients with AD with increased risk of death during hospitalization, leading to initial therapies seeking to improve survival. These results should be evaluated prospectively in future studies to establish their predictive power.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec678613
dc.identifier.issn1664-3224
dc.identifier.pmid28386264
dc.identifier.urihttps://hdl.handle.net/2445/139670
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fimmu.2017.00337
dc.relation.ispartofFrontiers in Immunology, 2017, vol. 8, p. 337
dc.relation.urihttps://doi.org/10.3389/fimmu.2017.00337
dc.rightscc-by (c) Carrizosa, Jorge Armando et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationUnitats de cures intensives
dc.subject.classificationMalalties autoimmunitàries
dc.subject.classificationMortalitat
dc.subject.classificationColòmbia
dc.subject.otherIntensive care units
dc.subject.otherAutoimmune diseases
dc.subject.otherMortality
dc.subject.otherColombia
dc.titleFactors associated with mortality in patients with autoimmune diseases admitted to the Intensive Care Unit in Bogota, Colombia.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
678613.pdf
Mida:
151.49 KB
Format:
Adobe Portable Document Format